A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis have?
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis has 1,818 citations in the OpenAlex counts ScholarIQ stores.
When was A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis published?
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis has 2024 year in the ScholarIQ index.
What is the open-access status of A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis?
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis has green oa status in the ScholarIQ index.
What is the DOI of A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis?
The DOI for A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis is on the source record.
What is the PMID of A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis?
The PMID for A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis is on the source record.
What is the OpenAlex record for A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis?
The OpenAlex for A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis is on the source record.